{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:09:00Z","timestamp":1781417340393,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K07080"],"award-info":[{"award-number":["JP20K07080"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22590235"],"award-info":[{"award-number":["JP22590235"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26670181"],"award-info":[{"award-number":["JP26670181"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.lfs.2021.119043","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:50:18Z","timestamp":1610538618000},"page":"119043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Azelnidipine treatment reduces the expression of Cav1.2 protein"],"prefix":"10.1016","volume":"269","author":[{"given":"Fumiaki","family":"Nasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kurakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Norota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119043_bb0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1152\/physrev.00016.2013","article-title":"L-type CaV1.2 calcium channels: from in vitro findings to in vivo function","volume":"94","author":"Hofmann","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2021.119043_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2021.119043_bb0015","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1093\/emboj\/cdg583","article-title":"Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation","volume":"22","author":"Moosmang","year":"2003","journal-title":"EMBO J."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2021.119043_bb0020","first-page":"1","article-title":"Vascular effects of calcium channel antagonists: new evidence","volume":"65","author":"Richard","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2021.119043_bb0025","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/0002-9149(87)90078-6","article-title":"Differences in cardiovascular profile among calcium antagonists","volume":"59","author":"Taira","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2021.119043_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/clpt.1987.5","article-title":"Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans","volume":"41","author":"Kleinbloesem","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.119043_bb0035","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1016\/0895-7061(96)87762-4","article-title":"Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines","volume":"9","author":"Leenen","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2021.119043_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.11.3_Pt_2.II42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2021.119043_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003495-199855040-00003","article-title":"The classification of calcium antagonists and their selection in the treatment of hypertension","volume":"55","author":"L\u00fcscher","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2021.119043_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2165\/00003495-198734050-00005","article-title":"\u2018Second generation\u2019 dihydropyridine calcium antagonists","volume":"34","author":"Freedman","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2021.119043_bb0055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2165\/00003495-200363230-00004","article-title":"Azelnidipine","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2021.119043_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40268-013-0006-8","article-title":"Inhibitory effects of azelnidipine tablets on morning hypertension","volume":"13","author":"Kario","year":"2013","journal-title":"Drugs R D"},{"key":"10.1016\/j.lfs.2021.119043_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1291\/hypres.26.201","article-title":"Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure","volume":"26","author":"Kuramoto","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2021.119043_bb0070","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(25)12561-3","article-title":"Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site","volume":"27","author":"Rhodes","year":"1985","journal-title":"Mol.Pharm."},{"key":"10.1016\/j.lfs.2021.119043_bb0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1248\/bpb.19.430","article-title":"Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients","volume":"19","author":"Shimada","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2021.119043_bb0080","doi-asserted-by":"crossref","first-page":"47163","DOI":"10.1074\/jbc.M108049200","article-title":"Cloning of a functional splice variant of L-type calcium channel \u03b22 subunit from rat heart","volume":"276","author":"Yamada","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119043_bb0085","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41598-017-05456-0","article-title":"Midnolin is a novel regulator of parkin expression and is associated with Parkinson\u2019s disease","volume":"7","author":"Obara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119043_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2021.119043_bb0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/acschemneuro.6b00454","article-title":"Stapled voltage-gated calcium channel (CaV) \u03b1-interaction domain (AID) peptides act as selective protein-protein interaction inhibitors of CaV function","volume":"8","author":"Findeisen","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2021.119043_bb0100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02588","article-title":"Structure of a complex between a voltage-gated calcium channel \u03b2-subunit and an \u03b1-subunit domain","volume":"429","author":"Van Petegem","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119043_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0076-6879(07)38006-3","article-title":"Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis","volume":"438","author":"Kirchhausen","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2021.119043_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113628","article-title":"KCNQ1 is internalized by activation of \u03b11 adrenergic receptors","volume":"169","author":"Kurakami","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119043_bb0115","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1007\/s00018-008-8354-1","article-title":"Endosome protein sorting: motifs and machinery","volume":"65","author":"Seaman","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2021.119043_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm1315","article-title":"Endocytic recycling","volume":"5","author":"Maxfield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119043_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ddr.10124","article-title":"1,4-Dihydropyridine calcium channel ligands: selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors","volume":"58","author":"Triggle","year":"2003","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.lfs.2021.119043_bb0130","doi-asserted-by":"crossref","first-page":"I10","DOI":"10.1016\/0002-9149(89)90956-9","article-title":"Pharmacologic profile of amlodipine","volume":"64","author":"Burges","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2021.119043_bb0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00005344-199423030-00016","article-title":"Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors","volume":"23","author":"Yamada","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119043_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0021-5198(19)40137-6","article-title":"Antihypertensive effects of CS-905, a novel dihydropyridine Ca++channel blocker","volume":"51","author":"Oizumi","year":"1989","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119043_bb0145","doi-asserted-by":"crossref","first-page":"F1308","DOI":"10.1152\/ajprenal.00423.2010","article-title":"AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells","volume":"299","author":"Alzamora","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2021.119043_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10474-z","article-title":"Prolonged AT1R activation induces CaV1.2 channel internalization in rat cardiomyocytes","volume":"7","author":"Hermosilla","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119043_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/19336950.2017.1405196","article-title":"Regulation of Kv1.4 potassium channels by PKC and AMPK kinases","volume":"12","author":"Andersen","year":"2018","journal-title":"Channels"},{"key":"10.1016\/j.lfs.2021.119043_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuron.2013.02.032","article-title":"Competition between \u03b1-actinin and Ca2+-calmodulin controls surface retention of the L-type Ca2+ channel CaV1.2","volume":"78","author":"Hall","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2021.119043_bb0165","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.hrthm.2011.04.034","article-title":"Protein kinase C downregulates IKs by stimulating KCNQ1-KCNE1 potassium channel endocytosis","volume":"8","author":"Kanda","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lfs.2021.119043_bb0170","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1113\/jphysiol.2013.251678","article-title":"Oestrogen promotes KCNQ1 potassium channel endocytosis and postendocytic trafficking in colonic epithelium","volume":"591","author":"Rapetti-Mauss","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2021.119043_bb0175","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1159\/000341480","article-title":"Downregulation of Kv1.5 K+ channels by the AMP-activated protein kinase","volume":"30","author":"Mia","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2021.119043_bb0180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neuron.2007.07.024","article-title":"The tumor suppressor eIF3e mediates calcium-dependent internalization of the L-type calcium channel CaV1.2","volume":"55","author":"Green","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2021.119043_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/385260a0","article-title":"Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression","volume":"385","author":"Hardingham","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119043_bb0190","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCRESAHA.117.310355","article-title":"Calcium signaling and transcriptional regulation in cardiomyocytes","volume":"121","author":"Dewenter","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2021.119043_bb0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.RES.0000216596.73005.3c","article-title":"Excitation-transcription coupling in arterial smooth muscle","volume":"98","author":"Wamhoff","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2021.119043_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrm3588","article-title":"Organization of the ER-Golgi interface for membrane traffic control","volume":"14","author":"Brandizzi","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119043_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tibs.2018.06.005","article-title":"Quality control in the endoplasmic reticulum: crosstalk between ERAD and UPR pathways","volume":"43","author":"Hwang","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2021.119043_bb0210","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/1873-3468.13571","article-title":"Emerging lysosomal pathways for quality control at the endoplasmic reticulum","volume":"593","author":"De Leonibus","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2021.119043_bb0215","doi-asserted-by":"crossref","first-page":"19348","DOI":"10.1074\/jbc.273.30.19348","article-title":"Multiple modulation pathways of calcium channel activity by a \u03b2 subunit: direct evidence of \u03b2 subunit participation in membrane trafficking of the \u03b11C subunit","volume":"273","author":"Yamaguchi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119043_bb0220","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1074\/jbc.274.4.2137","article-title":"Complexes of the \u03b11C and \u03b2 subunits generate the necessary signal for membrane targeting of class C L-type calcium channels","volume":"274","author":"Gao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119043_bb0225","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00424-014-1636-6","article-title":"Ubiquitin-specific protease USP2-45 acts as a molecular switch to promote \u03b12\u03b4-1-induced downregulation of Cav1.2 channels","volume":"467","author":"Rougier","year":"2015","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2021.119043_bb0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nn.2712","article-title":"The Cav\u03b2 subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels","volume":"14","author":"Altier","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2021.119043_bb0235","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/CIRCULATIONAHA.117.031231","article-title":"Regulation of blood pressure by targeting CaV1.2-galectin-1 protein interaction","volume":"138","author":"Hu","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2021.119043_bb0240","doi-asserted-by":"crossref","first-page":"E10566","DOI":"10.1073\/pnas.1813157115","article-title":"Small-molecule CaV\u03b11\u00b7CaV\u03b2 antagonist suppresses neuronal voltage-gated calcium-channel trafficking","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119043_bb0245","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/sj.bjp.0706919","article-title":"The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle","volume":"149","author":"Zhu","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119043_bb0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jphs.DTJ05001X","article-title":"Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker","volume":"100","author":"Yao","year":"2006","journal-title":"J. Pharmacol. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:42:22Z","timestamp":1772732542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052100028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":50,"alternative-id":["S002432052100028X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119043","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azelnidipine treatment reduces the expression of Cav1.2 protein","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119043"}}